Stock Picks: Religare bets on these 4 midcap stocks, sees 16-21% upside in one year, do you own?

livemint.com:

1.Mphasis:
At a current market price (CMP) of ₹2,442, Religare has initiated a ‘buy’ rating on the stock and sees a potential upside of 21.2 per cent in the next 9-12 months. The IT solutions provider commands a market capitalisation of ₹46,034 crore Despite the macro challenges the IT sector is facing for the near term, we believe Mphasis strategy of investing in right growth areas such as new generation technology, partnering with companies for technology and adhering to customer centric approach will aid growth for the company,'' said Religare Broking.

‘’Also, management's optimistic view on margin range because of improving utilizations and gaining large deals would support growth. We have estimated its revenue/EBIT to grow at a 15 per cent & 19 per cent compound annual growth rate (CAGR) over FY23-25,'' added the brokerage.